ClinicalTrials.gg
Not yet recruitingNCT07880457Updated Oct 19, 2026

Improving Perinatal Mental Health Through a Collaborative, Community Health Worker and Social Worker Intervention

An interventional study of Patient Navigation (PN) and Problem Solving Therapy (PST) in Perinatal Anxiety and Perinatal Depression, sponsored by American University. Not yet recruiting at 1 site in United States. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-19.

Sponsored by American University · Not applicable, Interventional, and Health services research

Updated Oct 19, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
45
Allocation
Not applicable
Ages
18 Years and older
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 654 studies in Psychological Well-Being with a site in United States — 189 open to participants now, 240 under way, 1 of them phase 3. Psychological Well-Being · United States.

Planned enrollment
428th of 572
45 · median 116
Started
2027
with 7 others
No phase
514 of 654
153 open now
Primary completion
2027-09
later than 154 of 238 live
Registered
514th of 654
by date

Among the 654 studies in Psychological Well-Being with a site in United States, this one is the 428th largest by planned enrollment of the 572 interventional ones that give a count, is one of 8 that started in 2027, is one of 514 with no phase, reaches primary completion later than 154 of the 238 other live ones, and was the 514th registered.

Psychological Well-Being

2,193 studies on the registry are indexed under Psychological Well-Being; 728 are open to participants now.

This study's planned enrollment of 45 is below the median of 110 across 1,796 interventional studies indexed under Psychological Well-Being.

Browse Psychological Well-Being studies →

Open to participants now

189 of the 654 studies in Psychological Well-Being with a site in United States are open now.

All 189 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 402 Psychological Well-Being studies recruiting now, 218 (54%) set no upper age limit and 158 (39%) stop at 75 or younger; 120 take children under 18; 203 take healthy volunteers.

This study: 18 Years and older · female · no healthy volunteers.

The full table on the hub →
Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 654 studies in Psychological Well-Being with a site in United States, or all of them as a file.
02

Study summary

The goal of this clinical trial is to learn if an intervention can improve mental health outcomes among pregnant and postpartum Latinas. The main questions it answers are:

Is a collaborative, community health worker and social worker intervention is feasible within a community health setting? Is a collaborative, community health worker and social worker intervention is acceptable among Latina individuals in Central Texas? Do participants experience an improvement in perinatal mental health outcomes during or after the collaborative intervention?

Participants will:

  • Receive 3 community health worker and social worker sessions during pregnancy.
  • Receive 3 community health worker and social worker sessions postpartum (up to 12 weeks).
  • Complete a survey at three timepoints (baseline, 2 weeks postpartum and 12 weeks postpartum).
03

Conditions studied

  • Perinatal Anxiety
  • Perinatal Depression

Keywords

  • perinatal
  • mental health
  • community health worker
  • social worker
  • Latina
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Pregnant
  • Identify as Hispanic or Latina
  • Receive social services from El Buen Samaritano and/or obstetric services from LoneStar Circle of Care
  • Between 20- and 32-weeks' gestation
  • 18 years or older
  • Screen positive for depression or anxiety (PHQ-4≥3 on either subscale)

Exclusion criteria

Exclusion Criteria:

  • Not pregnant
  • Do not identify as Hispanic or Latina
  • Do not receive services at El Buen Samaritano or LoneStar Circle of Care
  • Before 20 weeks pregnant or after 32 weeks pregnant
  • Under 18
  • Do not screen positive for depression or anxiety
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
45 participants (estimated)

Study arms

  • Experimental
    CHW+SW intervention

    Community health workers (CHWs) will provide patient navigation to assess and address health related social needs, while social worker (SWs) will focus on mental health needs, and provide a standardized, PST intervention.

    Behavioral: Patient Navigation (PN) · Behavioral: Problem Solving Therapy (PST)

Interventions

  • BehavioralPatient Navigation (PN)

    Patient navigation (PN) is an evidence-based intervention that removes barriers to healthcare services. PN typically supports patients by identifying healthcare services and addressing any access barriers such as location, cost, or transportation.

  • BehavioralProblem Solving Therapy (PST)

    Problem solving therapy (PST) is an evidence-based, mental health intervention that consists of cognitive behavioral and problem-solving strategies aimed at improving mental health.

06

What researchers measure

Primary outcomes

  1. Feasibility- Recruitment

    Feasibility will be assessed based on recruitment metrics, which includes the number and percent of patients screened and enrolled per week.

    Time frame: From enrollment until we reach 45 participants (Up to 24 weeks)

  2. Feasibility- Attrition

    Feasibility will be assessed based on attrition, or the proportion of participants who withdraw from the study before its completion.It will be calculated as the number of participants lost to follow-up divided by the total number initially enrolled.

    Time frame: From enrollment until at least 30 participants complete the study (Up to 24 weeks)

  3. Feasibility- Retention

    Feasibility will be assessed based on retention, or the proportion of participants who remain in the study through to its conclusion.

    Time frame: From enrollment to the end of the study at 8 weeks postpartum

  4. Feasibility- Completion of Intervention

    Feasibility will be assessed based on number of participants who complete of Intervention, which is the percentage of participants who receive the "full dose" or intended components of the intervention.

    Time frame: From enrollment to the end of the study at 8 weeks postpartum

  5. Feasibility- Duration

    Feasibility will be assessed based on duration, or the average amount of time required to complete the intervention per participant.

    Time frame: From enrollment to the end of the study at 8 weeks postpartum

  6. Feasibility- Completion of Study Assessments

    Feasibility will be assessed based on completion of study assessments. This will be defined as the proportion of participants who complete required data collection activities at each timepoint.

    Time frame: From enrollment to the end of the study at 8 weeks postpartum

  7. Acceptability

    Acceptability will be assessed based on patient satisfaction, retention, and qualitative interviews.

    Time frame: From enrollment to the end of the study at 8 weeks postpartum

Secondary outcomes

  1. Depression: Edinburgh Postpartum Scale (EPDS)

    The Edinburgh Postnatal Depression Scale (EPDS) is a 10-item self-report questionnaire designed to screen for symptoms of depression during the perinatal period. The Edinburgh Postnatal Depression Scale (EPDS) has been validated for use with Latina populations, with studies showing a Spanish version performs adequately.

    Time frame: From enrollment to the end of the study at 8 weeks postpartum

  2. Anxiety: Generalized Anxiety Disorder-7

    The Generalized Anxiety Disorder-7 (GAD-7) is a 7-item self-report scale used to screen for and assess the severity of generalized anxiety disorder. The GAD-7 has been validated in both general and perinatal populations, demonstrating strong psychometric properties, including good reliability and construct validity.

    Time frame: From enrollment to the end of the study at 8 weeks postpartum

  3. Post-traumatic stress disorder: Impact of Event Scale-6

    The Impact of Event Scale-6 (IES-6) is a brief, 6-item self-report measure used to assess post-traumatic stress symptoms in response to a specific stressful or traumatic event. The IES-6 has demonstrated strong reliability and validity in perinatal populations, including women who have experienced traumatic birth or pregnancy complications.

    Time frame: From enrollment to the end of the study at 8 weeks postpartum

  4. Health related social needs: PhenX

    The PhenX Toolkit is a publicly available resource that provides standardized, consensus-based measures for use in biomedical and public health research. It includes a wide range of validated instruments to measure health related social needs. For example, the Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences (PRAPARE) is a nationally recognized, evidence-informed tool designed to assess social determinants of health in clinical and community settings. The PRAPARE tool has been widely used and validated in diverse populations, including Latina communities, and is available in Spanish.

    Time frame: From enrollment to the end of the study at 8 weeks postpartum

  5. Respectful Care: MADM

    The Mothers' Autonomy in Decision Making (MADM) scale is a 7-item, validated self-report measure that evaluates the extent to which individuals feel they were supported to make informed decisions about their maternity care. MADM has been validated with perinatal and Latina populations.

    Time frame: From enrollment to the end of the study at 8 weeks postpartum

  6. Respectful Care: MORi

    The Mothers on Respect Index (MORi) is a 14-item measure that assesses the degree of respectful, dignified, and non-coercive care received during maternity care. MORi has been validated with perinatal and Latina populations.

    Time frame: From enrollment to the end of the study at 8 weeks postpartum

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Yes — All individual participant data that is shared will be aggregated and deidentified. Access to this data will require PI permission that will include conditions for using the data such as time limitations and co-authorship.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form

Time frame: The investigators anticipate all study data will be available for analysis by 03/01/2028.

Access criteria: All individual participant data that is shared will be aggregated and deidentified. Access to this data will require PI permission that will include conditions for using the data such as time limitations and co-authorship. Data will be stored on encrypted, web-based servers via OneDrive. Metadata (e.g., intervention protocols, interview guides, data dictionaries, etc.) will be stored via the American University Research Archive: https://aura.american.edu/

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jan 2027; primary completion for Sep 2027, 8 months later.

Of 1,259 non-industry interventional studies with no phase under Psychological Well-Being, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 34. This study's planned 8 months is below that.

Counting every sponsor, half of 1,302 studies reached it within 16 months; a quarter within 7 and three quarters within 34.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 1, 2025
First posted
Oct 19, 2026
StartEst.
Jan 1, 2027
Primary completionEst.
Sep 1, 2027
CompletionEst.
Sep 1, 2027
Last update
Oct 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 19, 2026
Show all 1 update
  1. Oct 19, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07880457
Lead sponsor
American University
Responsible party
Liana Petruzzi (Assistant Professor, American University) — Principal investigator
First posted
Oct 19, 2026
Start date
Jan 1, 2027 (estimated)
Primary completion
Sep 1, 2027 (estimated)
Completion
Sep 1, 2027 (estimated)
Last update
Oct 19, 2026

Study contacts

Principal Investigator
Contact
lpetruzzi@american.edu
202-885-3745
Liana Petruzzi, PhD, LCSW
principal investigator · American University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion